Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives

Asad Ullah,Jaffar Khan,Abdul Waheed,Nitasha Sharma,Elizabeth K. Pryor,Tanner R. Stumpe,Luis Velasquez Zarate,Frederick D. Cason,Suresh Kumar,Subhasis Misra,Sravan Kavuri,Hector Mesa,Nitin Roper,Shahin Foroutan,Nabin Raj Karki,Jaydira Del Rivero,William F. Simonds,Nagla Abdel Karim
DOI: https://doi.org/10.3390/cancers14061426
2022-03-10
Cancers
Abstract:Introduction: Parathyroid carcinoma (PC) is an extremely rare entity, with a frequency of 0.005% of all malignancies. Most data related to this rare disease are limited to case series and a few database studies. We present a large database study that aims to investigate the demographic, clinical, and pathological factors, prognosis, and survival of PC. Methods: Data of parathyroid carcinoma were extracted from the Surveillance, Epidemiology, and End Results (SEER) diagnosed between 1975 and 2016. Results: PC had a slightly higher incidence in men (52.2%, p 40 years, male sex, Caucasian race, distant spread, and poorly differentiated grade as independent risk factors for mortality (p < 0.001). Conclusion: PC is a very rare tumor mostly affecting Caucasian individuals in the fifth decade. Older age, poor histologic differentiation, and distant metastasis are associated with a worse prognosis. Surgical resection offers the best survival outcome. To better understand the pathogenesis and factors affecting survival, all PC patients should be enrolled in national and international registries.
oncology
What problem does this paper attempt to address?